Search Results | Scholarly Articles, Journals, and E-Books

Select item for more details and to access through your institution.

The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.
Published in:
2008
By:
- Chapiro, E.;
- Radford-Weiss, I.;
- Bastard, C.;
- Luquet, I.;
- Lefebvre, C.;
- Callet-Bauchu, E.;
- Leroux, D.;
- Talmant, P.;
- Mozziconacci, M.-J.;
- Mugneret, F.;
- Struski, S.;
- Raynaud, S.;
- Andrieux, J.;
- Barin, C.;
- Jotterand, M.;
- Mossafa, H.;
- Ramond, S.;
- Terré, C.;
- Lippert, E.;
- Berger, F.
Publication type:
Letter
Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.
Published in:
2008
By:
- Caocci, G.;
- Atzeni, S.;
- Orrù, N.;
- Azzena, L.;
- Martorana, L.;
- Littera, R.;
- Ledda, A.;
- La Nasa, G.
Publication type:
Letter
Association of KIR2DS4 and its variant KIR1D with leukemia.
Published in:
2008
By:
- Giebel, S.;
- Nowak, I.;
- Wojnar, J.;
- Krawczyk-Kulis, M.;
- Holowiecki, J.;
- Kyrcz-Krzemien, S.;
- Kusnierczyk, P.
Publication type:
Letter
Reply to: Association of KIR2DS4 and its variant KIR1D with leukemia.
Published in:
2008
By:
- Verheyden, S.;
- Demanet, C.
Publication type:
Letter
Reply to Verheyden and Demanet.
Published in:
2008
By:
- Giebel, S.;
- Nowak, I.;
- Majorczyk, E.;
- Kusnierczyk, P.
Publication type:
Letter
Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.
Published in:
2008
By:
- Berger, M. G.;
- Berger, J.;
- Richard, C.;
- Jeanpierre, S.;
- Nicolini, F. E.;
- Tournilhac, O.;
- Michallet, M.;
- Satta, V. M.
Publication type:
Letter
Ex vivo priming of CD4 T cells converts immunological tolerance into effective antitumor immunity in a murine model of acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 2070, doi. 10.1038/leu.2008.193
By:
- Hegazy, A. N.;
- Klein, C.
Publication type:
Article
Impact of comorbidity indexes on non-relapse mortality.
Published in:
2008
By:
- Xhaard, A.;
- Porcher, R.;
- Chien, J. W.;
- de Latour, R. P.;
- Robin, M.;
- Ribaud, P.;
- Rocha, V.;
- Devergie, A.;
- Ferry, C.;
- Martin, P. J.;
- Socié, G.;
- Socié, G
Publication type:
journal article
HOX expression patterns identify a common signature for favorable AML.
Published in:
2008
By:
- Andreeff, M.;
- Ruvolo, V.;
- Gadgil, S.;
- Zeng, C.;
- Coombes, K.;
- Chen, W.;
- Kornblau, S.;
- Barón, A. E.;
- Drabkin, H. A.;
- Barón, A E
Publication type:
journal article
Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.
Published in:
2008
By:
- Berger, M. G.;
- Berger, J.;
- Richard, C.;
- Jeanpierre, S.;
- Nicolini, F. E.;
- Tournilhac, O.;
- Michallet, M.;
- Maguer-Satta, V.
Publication type:
Correction Notice
Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G<sub>1</sub> cell cycle arrest and apoptosis.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 2091, doi. 10.1038/leu.2008.204
By:
- Gu, L.;
- Gao, J.;
- Li, Q.;
- Zhu, Y. P.;
- Jia, C. S.;
- Fu, R. Y.;
- Chen, Y.;
- Liao, Q. K.;
- Ma, Z.
Publication type:
Article
Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 2029, doi. 10.1038/leu.2008.206
By:
- Kennedy, J. A.;
- Barabé, F.
Publication type:
Article
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance.
Published in:
2008
By:
- McCubrey, J. A.;
- Abrams, S. L.;
- Ligresti, G.;
- Misaghian, N.;
- Wong, E. W. T.;
- Steelman, L. S.;
- Bäsecke, J.;
- Troppmair, J.;
- Libra, M.;
- Nicoletti, F.;
- Molton, S.;
- McMahon, M.;
- Evangelisti, C.;
- Martelli, A. M.;
- Bäsecke, J
Publication type:
journal article
Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 2097, doi. 10.1038/leu.2008.213
By:
- Klier, M.;
- Anastasov, N.;
- Hermann, A.;
- Meindl, T.;
- Angermeier, D.;
- Raffeld, M.;
- Fend, F.;
- Quintanilla-Martinez, L.
Publication type:
Article
Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.
Published in:
2008
By:
- Castro, J. E.;
- Sandoval-Sus, J. D.;
- Bole, J.;
- Rassenti, L.;
- Kipps, T. J.
Publication type:
journal article
Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 2054, doi. 10.1038/leu.2008.217
By:
- Müller, I.;
- Vaegler, M.;
- Holzwarth, C.;
- Tzaribatchev, N.;
- Pfister, S. M.;
- Schütt, B.;
- Reize, P.;
- Greil, J.;
- Handgretinger, R.;
- Rudert, M.
Publication type:
Article
BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features.
Published in:
2008
By:
- Cross, N. C. P.;
- Daley, G. Q.;
- Green, A. R.;
- Hughes, T. P.;
- Jamieson, C.;
- Manley, P.;
- Mughal, T.;
- Perrotti, D.;
- Radich, J.;
- Skoda, R.;
- Soverini, S.;
- Vainchenker, W.;
- Verstovsek, S.;
- Villeval, J.-L.;
- Goldman, J. M.
Publication type:
Editorial
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 2020, doi. 10.1038/leu.2008.253
By:
- Landolfi, R.;
- Di Gennaro, L.;
- Falanga, A.
Publication type:
Article
Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 1990, doi. 10.1038/leu.2008.280
By:
- Kiladjian, J.-J.;
- Chomienne, C.;
- Fenaux, P.
Publication type:
Article
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.
Published in:
2008
By:
- Gotlib, J.;
- Cools, J.
Publication type:
journal article
Miscreant myeloproliferative disorder stem cells.
Published in:
Leukemia (08876924), 2008, v. 22, n. 11, p. 2011, doi. 10.1038/leu.2008.290
By:
- Jamieson, C. H. M.;
- Barroga, C. F.;
- Vainchenker, W. P.
Publication type:
Article
STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma.
Published in:
2008
By:
- Ritz, O.;
- Guiter, C.;
- Dorsch, K.;
- Dusanter-Fourt, I.;
- Wegener, S.;
- Jouault, H.;
- Gaulard, P.;
- Castellano, F.;
- Möller, P.;
- Leroy, K.;
- Möller, P
Publication type:
Letter
Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia.
Published in:
2008
By:
- Burcu, M.;
- O'Loughlin, K. L.;
- Ford, L. A.;
- Baer, M. R.
Publication type:
Letter
In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells—clinical implications.
Published in:
2008
By:
- Siegel, S.;
- Friedrichs, B.;
- Budde, A.-K.;
- Barsoum, A.;
- Coggin, J.;
- Tiemann, M.;
- Kabelitz, D.;
- Zeis, M.
Publication type:
Letter
The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group.
Published in:
2008
By:
- Schwarz, J.;
- Penka, M.;
- Indrák, K.;
- Pospíšlova, D.;
- Pytlík, R.;
- Dulíček, P.;
- Doubek, M.;
- Křen, L.;
- Campr, V.
Publication type:
Letter
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.
Published in:
2008
By:
- Mazzi, B.;
- Clerici, T. D.;
- Zanussi, M.;
- Lupo Stanghellini, M. T.;
- Vago, L.;
- Sironi, E.;
- Peccatori, J.;
- Bernardi, M.;
- Carrera, P.;
- Palini, A.;
- Rossini, S.;
- Bordignon, C.;
- Bonini, C.;
- Ferrari, M.;
- Ciceri, F.;
- Fleischhauer, K.
Publication type:
Letter

Found: 26